Amy Welsh
Corporate Officer/Principal at AGILE THERAPEUTICS, INC.
Net worth: 5 400 $ as of 30/04/2024
Profile
Amy Welsh is currently the Chief Commercial Officer at Agile Therapeutics, Inc. She previously worked as the Vice President-Marketing at Antares Pharma, Inc. from 2017 to 2020.
Ms. Welsh completed her undergraduate degree at LaSalle University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AGILE THERAPEUTICS, INC.
0.20% | 28/06/2023 | 13,500 ( 0.20% ) | 5 400 $ | 30/04/2024 |
Amy Welsh active positions
| Companies | Position | Start |
|---|---|---|
| AGILE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/11/2022 |
Former positions of Amy Welsh
| Companies | Position | End |
|---|---|---|
| ANTARES PHARMA, INC. | Sales & Marketing | 01/05/2020 |
Training of Amy Welsh
| LaSalle University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AGILE THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
- Stock Market
- Insiders
- Amy Welsh